Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Results of General Meeting

26th Jun 2026 14:30

RNS Number : 0139K

EDX Medical Group PLC

26 June 2026

EDX Medical Group plc

("EDX Medical" or the "Company")

Results of General Meeting

CAMBRIDGE, UK: EDX Medical (TIDM: EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer and infectious diseases, today announces the results of its general meeting, held at the Mezzanine Room, Royal Society of Medicine, 1 Wimpole Street, London, W1G 0AE on 26 June 2026 at 2.00 p.m.

Both resolutions put to members were passed on a poll. Resolution 1 was passed as an ordinary resolution and resolution 2 was passed as a special resolution.

The number of votes cast for and against each of the resolutions proposed, and the number of votes withheld were as follows:

Resolution

Votes for

Votes against

Votes withheld

Resolution 1 (Ordinary)

To authorise the directors to allot equity securities in line with the limits set out in the Notice of General Meeting.

201,208,426

94.41

11,913,139

5.59

Resolution 2 (Special)

To authorise the directors, subject to resolution 1, to allot equity securities for cash as if section 561 of the Companies Act 2006 did not apply, with the limits set out in the Notice of General Meeting.

201,216,561

94.41

11,904,843

5.59

161

As at 26 June 2026, there were 411,994,583 ordinary shares in issue with no shares held in treasury, resulting in total voting rights of 411,994,583. Shareholders are entitled to one vote per share. Votes withheld are not votes in law and so have not been included in the calculation of the proportion of votes for and against a resolution.

The full text of each resolution is available in the Notice of General Meeting, published on our website at https://edxmedical.co.uk/documents/.

For enquiries, please contact:

EDX Medical Group plc
Dr Mike Hudson (Chief Executive Officer)	+44 (0)7812 345 301
Canaccord Genuity Limited (Nominated Adviser and Broker)
Stuart Andrews	+44 (0) 20 7523 8318
Media House International
Ramsay Smith Gary McQueen	+44 (0)7788 414856 [email protected] + 44 (0)7834 694609 [email protected]
IFC Advisory (Investor Relations)
Graham Herring Tim Metcalfe	+44 (0) 203 934 6630

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ROMFLFFVRLIRFIR

Related Shares:

FTSE 100 Latest

Value10,529.39

Change31.10